Key oncology conferences like ASCO, ASH, and ESMO drive investment-informing clinical research, with recent ESMO 2024 data highlighting significant advancements in immunotherapy. Merck's ...

The results of the open-label DESTINY-Breast12 trial – reported at the ESMO cancer congress in Barcelona this weekend – showed that nearly two-thirds (61.6%) of patients with brain metastases ...

Jazz’s Global Head of R&D Robert Iannone, M.D., told Fierce Biotech ahead of ESMO that today’s updated results “reaffirm zanidatamab’s potential as a foundational treatment for patients ...

Taking to the stage for the 2024 European Society for Medical Oncology (ESMO) Meeting in Barcelona, Spain, Exact Sciences said the study sought to simulate the screening population to predict the ...

Lantheus may have been hoping that “statistically significant” phase 3 data for its radioligand therapy would make a splash at ESMO, but not everyone is impressed. The biotech used the ...

Welcome, ladies and gentlemen, to AstraZeneca's Investor Conference Call ESMO 2024. Before I hand over to AstraZeneca's management team, I'd like to read the safe harbor statement. The Company ...

At the European Society of Medical Oncology (ESMO) Congress 2024, recent results from the single-arm open-label DESTINYBreast-012 trial evaluating Daiichi Sankyo’s Enhertu (trastuzumab ...

BARCELONA, Spain — Ten years ago, a new type of cancer treatment reached the market. It worked by rousing the body’s own immune cells to attack tumors. Within months, regulators had approved ...

Press conference: 12:30-13:15 CEST - ESMO Press Conference room, CC3 and virtually Presidential Symposium III, Eyes to the future: 16:30-18:15 CEST - Barcelona Auditorium - Hall 2 Organ agnostic ...

Source: Getty Images ESMO 2024 featured studies that may change clinical practice for a range of cancers as well as studies that highlight the need for new approaches to cancer treatment.

(UroToday.com) The 2024 ESMO annual meeting included a highlights session, featuring a presentation by Dr. Ursula Vogl discussing highlights of the ESMO 2024 prostate cancer sessions. The outline of ...

(UroToday.com) The 2024 ESMO annual meeting included a highlights session, featuring a presentation by Dr. Ignacio Duran discussing highlights of the ESMO 2024 non-prostate cancer sessions. Dr. Duran ...